Skip to content

Assessment of the Perceptions and Opinions of Staff Working of Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction (PERRCEP)

Assessment of the Perceptions and Opinions of Staff Working in Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06894589
Acronym
PERRCEP
Enrollment
800
Registered
2025-03-25
Start date
2024-10-01
Completion date
2025-05-01
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Harm Reduction, Prisoners

Brief summary

Evaluation, through an anonymous questionnaire, of the perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures in prison environment. The secondary objective of the study will be to assess training needs and explore factors associated with better adherence to the implementation of harm reduction measures.

Detailed description

A first contact will be made by email with the heads of institutions, directors of Penitentiary Rentegration Services), and coordinating doctors of healthcare units to inform them about the study's objectives and procedures, and to request their institution's and service's participation. If they agree to participate, volunteer key contacts will be identified in each institution to relay the information to the staff working in the institution and ensure the distribution of the questionnaire. The study's responsible doctor will meet with one of the resident investigators for a preliminary informational meeting with the institution's director, the SPIP director, and the identified key staff members. The questionnaires will be handed to the key contacts at that time. A non-opposition letter will be individually distributed with each anonymous questionnaire to provide further details about the study for which their participation is requested. After answering, participants will be able to place the questionnaire in the provided envelope, and then into a sealed ballot box. After the answering period, the investigator will go back to prisons and detention centers to collect the ballot boxes. The data from each paper questionnaire will be transcribed by the residents onto an online platform using the Lime Survey® software. The statistician of UBO (university of Brest) will have access to the data on Lime Survey® in order to perform the statistical analyses as described below. The statistician will make a descriptive analysis of the results and the an analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* working person of remand center of Brest, Vannes, Rennes, Saint-Malo, Lorient and Saint-Brieuc, who has answered the questionnaire * working person of detention center of Lorient and Rennes, who answered the questionnaire

Exclusion criteria

* person opposing participation in the study * person under legal protection measure

Design outcomes

Primary

MeasureTime frameDescription
perceptions and opinions of staff working in prisons and detention centers in Brittany regarding the consumption of illicit substances and harm reduction measures.from january 2025 to may 2025descriptive analysis of the results

Secondary

MeasureTime frameDescription
Assess training needs and research factors associated with improved adherence to harm reduction mesuresfrom january 2025 to may 2025An analytical study will research factors associated with improved adherence to harm reduction mesures : profession exercised; seniority; harm reduction training; age.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026